Fact CheckerSign in

NCT04678427Active, not recruiting

Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant

TEAM Me (Totally Excited About Moving, Mobility, and Exercise) Clinical Research Protocol

Source: ClinicalTrials.gov · Last updated 13 Oct 2026

Brief summary (registry, in English)

This clinical trial studies how well an exercise program (Totally Excited About Moving, Mobility, and Exercise \[TEAM Me\]) affects the exercise and dietary habits of pediatric and adolescents and young adults with cancer undergoing a blood stem cell transplant. TEAM Me is an exercise program that reinforces behavior, such as walking and other activities, using "tokens" (i.e. stickers) that can be redeemed for rewards. Participating in the exercise program may result in increased physical fitness, physical activity level, quality of life, and function in pediatric and adolescents and young adult patients with cancer.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
30 (actual)
First submitted
16 Dec 2020
Start date
13 Nov 2020
Primary completion date
31 Dec 2028
Lead sponsor
M.D. Anderson Cancer Center
NCT number
NCT04678427

What you commit to

  • Study type: Interventional
  • Participants enrolled: 30
  • From 13 Nov 2020 to the primary completion date, 31 Dec 2028
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • At MD Anderson HSCT patients admitted to adult units for their transplant will not be eligible as TEAM Me is an established program on the G9 Pediatrics Unit only

Other illness

  • Patients whose clinical status precludes them from participating in any physical activity including but not limited to: declining respiratory status, hypoxia requiring high flow nasal cannula (Vapotherm), hypotension, and active bleeding.

Who the study is looking for

  • Be admitted to an inpatient pediatric ward for the purpose of HSCT for the treatment of malignancy
  • Be greater than or equal to 6 years of age and less than 30 years of age
  • Participants or guardians are willing and able to give written informed consent either prior to admission or within 48 hours following admission and to comply with all of the study activities and procedures
  • Participants or guardians are willing and able to give written informed consent for protocol PA18-0130 (Pediatric Energy balance data repository protocol), companion protocol for the Fitbit application/assessment

Age in the registry: 6 years to 29 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
UT Southwestern/Simmons Cancer Center-Dallas
Coordinator of this site? Confirm its status
DallasUnited StatesUnknown status
M D Anderson Cancer Center
Coordinator of this site? Confirm its status
HoustonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.